It has antidepressant, nootropic and neuroprotective effects, and is under development for the treatment of dementia and Alzheimer's disease.
LY-404,187 has been demonstrated to enhance cognitive function in animal studies, and has also shown effects suggesting antidepressant action as well as having possible application in the treatment of schizophrenia, Parkinson's disease and ADHD.
Vabicaserin (SCA-136) is a selective 5-HT2C full agonist that was being investigated as an antidepressant and atypical antipsychotic and was later dropped by its developer, Wyeth.
On August 23, 2013, Alexis showed up at a Providence, Rhode Island VA emergency room complaining of insomnia, and he was prescribed 50 milligrams of Trazodone, a Serotonin antagonist and reuptake inhibitor antidepressant.